Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD)
CUSIP: 67577R102
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 71,813,353
- Total 13F shares
- 1,038,443
- Share change
- +148,363
- Total reported value
- $5,482,000
- Put/Call ratio
- 467%
- Price per share
- $5.28
- Number of holders
- 28
- Value change
- +$532,990
- Number of buys
- 19
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 67577R102?
CUSIP 67577R102 identifies IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 67577R102:
Top shareholders of IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Altium Capital Management LLC |
13F
|
Company |
0.55%
|
397,036
|
$2,306,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.17%
|
119,551
|
$693,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.16%
|
113,620
|
$660,000 | — | 31 Mar 2021 | |
| NORRIS PERNE & FRENCH LLP/MI |
13F
|
Company |
0.11%
|
78,909
|
$458,000 | — | 31 Mar 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.08%
|
57,536
|
$334,000 | — | 31 Mar 2021 | |
| COMERICA BANK |
13F
|
Company |
0.04%
|
30,000
|
$143,000 | — | 31 Mar 2021 | |
| Regency Capital Management Inc.\DE |
13F
|
Company |
0.02%
|
17,000
|
$99,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.02%
|
13,673
|
$79,000 | — | 31 Mar 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
13,389
|
$78,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
12,692
|
$74,000 | — | 31 Mar 2021 | |
| Stokes Family Office, LLC |
13F
|
Company |
0.02%
|
12,120
|
$70,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
11,300
|
$65,000 | — | 31 Mar 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
10,365
|
$60,000 | — | 31 Mar 2021 | |
| MCF Advisors LLC |
13F
|
Company |
0.01%
|
9,499
|
$55,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,156
|
$36,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,528
|
$15,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
2,207
|
$13,000 | — | 31 Mar 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
2,174
|
$13,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,810
|
$11,000 | — | 31 Mar 2021 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
600
|
$3,000 | — | 31 Mar 2021 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
15
|
$87 | — | 31 Mar 2021 |
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q2 2021
As of 30 Jun 2021,
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,038,443 shares.
The largest 10 holders included
MARSHALL WACE, LLP, Ikarian Capital, LLC, NORRIS PERNE & FRENCH LLP/MI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
21
Q2 2021 holders
28
Holder diff
7
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.